MedTech Europe report boosts optimism in ‘thriving’ EU medtech sector

MedTech Europe report boosts optimism in ‘thriving’ EU medtech sector


A new report by MedTech Europe indicates that Europe’s medical technology sector is continuing to innovate and grow in economic strength.

The trade body’s report revealed that Europe’s overall medical technology market was worth around €170bn ($198.6bn) in 2024, with the sector employing over 930,000 staff.

Germany represents the largegest EU market with a 25% market share, followed by France, the UK, Italy, and Spain in positions 2-4, respectively. The report also reveals that 90% of Europe’s 38,000 medical technology companies are tiny and medium-sized (SME) entities.

According to MedTech Europe, digital health is rapidly scaling in Europe as a result of the convergence between breakthrough technologies, patient empowerment, and systemic efficiencies.

The assertion reflects that this charge is being spearheaded by Germany and France due to the nation’s expanded access to digital health through established reimbursement frameworks.

Germany’s DiGA (Digital Health Applications) pathway to date includes reimbursement for 59 DiGA solutions, with the counattempt having now reached one million DiGA prescriptions issued since the pathway’s launch in 2020.

MedTech Europe commented: “Digital health is no longer optional. With strong political will, smart regulation, and continued investment in value-based innovation, Europe can lead the way in integrating digital health into every level of care.”

Medical technology applications with the European Patent Office (EPO) came in at 15,700 in 2024, corresponding to 7.9% of all EPOs.

Almost doubling EPO filings for pharma and biotech, the figure places medtech as the fourth highest among all industrial sectors in Europe for the year, behind digital communication, electrical machinery, and computer technology apparatus in third, second, and first place, respectively.

Of the patents, 40.5% were filed from EPO countries – including the EU27, UK, Norway and Switzerland – with 38.2% from the US and 21.3% originating from other countries.

Commenting on the report findings, MedTech Europe’s CEO Oliver Bisazza declared the publication “paints a clear picture” of medical technology’s contribution to both healthcare and the wider economy in Europe.

Bisazza declared: “Whether you are shaping policy, advancing innovation, delivering care, or simply curious about the impact of our sector, I invite you to explore these insights and better understand the indispensable role medical technology plays in strengthening health systems, supporting innovation, and improving life for people across Europe, and beyond.”

“MedTech Europe report boosts optimism in ‘thriving’ EU medtech sector” was originally created and published by Medical Device Network, a GlobalData owned brand.

 


The information on this site has been included in good faith for general informational purposes only. It is not intfinished to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *